Express Scripts

CVS Health names David Joyner head of Pharmacy Services; Amy Bricker becomes Chief Product Officer - Consumer

Retrieved on: 
Monday, January 23, 2023
CVS, Pharmacy, NYSE, Bricker, Joyner, CVS Caremark, Growth, Health, Record, CVS Health, Express Scripts, Management, Nursing, Lynch

David Joyner will rejoin the company as Executive Vice President and President of Pharmacy Services, while Amy Bricker has been named Executive Vice President and Chief Product Officer – Consumer.

Key Points: 
  • David Joyner will rejoin the company as Executive Vice President and President of Pharmacy Services, while Amy Bricker has been named Executive Vice President and Chief Product Officer – Consumer.
  • "David and Amy are accomplished leaders with proven track records of anticipating and meeting customer and client needs," said CVS Health President and CEO Karen S. Lynch.
  • Joyner, a former CVS Health executive, brings more than 34 years of health care and pharmacy benefit management experience to the company.
  • He has been a champion of affordable and accessible health care, previously serving as head of CVS Specialty and as Chief Transformation Officer.

Julia Brncic Joins EverQuote as General Counsel

Retrieved on: 
Tuesday, January 17, 2023
Corporation, Washington University in St. Louis, Security (finance), Polsinelli, Insurance, EverQuote, General counsel, Senior, Securities & Exchange Commission of Pakistan, Purdue University, JD, Risk, Growth, BA, Express Scripts, MBA, Management, Cigna

CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, is pleased to announce that Julia Brncic has joined as General Counsel and Corporate Secretary where she will lead the company’s legal and compliance efforts.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, is pleased to announce that Julia Brncic has joined as General Counsel and Corporate Secretary where she will lead the company’s legal and compliance efforts.
  • “Julia is a proven senior executive and legal thought leader who brings decades of insurance experience to our company,” said Jayme Mendal, CEO of EverQuote.
  • “EverQuote has built a strong employee-first culture of collaboration and innovation since its founding,” said Brncic.
  • I’m excited to join EverQuote’s team and look forward to playing a part in the company’s growth.”
    Before joining EverQuote, Ms. Brncic served as Senior Vice President, Chief Counsel and Corporate Secretary of Cigna, Vice President and Deputy General Counsel at Express Scripts, and was a shareholder at the Polsinelli law firm.

Evernorth Names Adam Kautzner President, Express Scripts

Retrieved on: 
Wednesday, January 18, 2023
Doctor of Pharmacy, Express, Senior, NYSE, Purdue University, Growth, Express Scripts, Cigna, Supply chain, Management, Pharmacy

BLOOMFIELD, Conn., Jan. 18, 2023 /PRNewswire/ -- Evernorth, the health services business of Cigna Corporation (NYSE: CI), today announced the promotion of Adam Kautzner, PharmD, to president, Express Scripts.

Key Points: 
  • BLOOMFIELD, Conn., Jan. 18, 2023 /PRNewswire/ -- Evernorth, the health services business of Cigna Corporation (NYSE: CI), today announced the promotion of Adam Kautzner, PharmD, to president, Express Scripts.
  • Kautzner brings decades of experience to the role and most recently served as Senior Vice President of Supply Chain, leading pharmaceutical and retail network contracting, retail network contracting and drug sourcing for Express Scripts® Pharmacy and Accredo Pharmacy.
  • In prior roles, Kautzner served as Chief Pharma Trade Relations Officer and Vice President, Supply Chain Product & Strategy.
  • He earned his doctorate of pharmacy from St. Louis College of Pharmacy and Authorized Nuclear Pharmacist certification from Purdue University.

Cigna Corporation Announces Appearance at the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, December 20, 2022
Health, NYSE, Internet, Pharmacy, Conference, Express Scripts, Health insurance, Cigna

BLOOMFIELD, Conn., Dec. 20, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced today that David Cordani, chairman and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 in San Francisco, CA.

Key Points: 
  • BLOOMFIELD, Conn., Dec. 20, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced today that David Cordani, chairman and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 in San Francisco, CA.
  • Cigna Corporation is a global health services company dedicated to improving the health, well-being and peace of mind of those we serve.
  • Cigna maintains sales capability in over 30 countries and jurisdictions, and has over 190 million customer relationships around the world.
  • To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com .

Cigna Named Corporate Sustainability Leader by Dow Jones for Sixth Consecutive Year

Retrieved on: 
Monday, December 19, 2022
Cigna, Spouse, Child, Health, Grandparent, NYSE, Pharmacy, Transport, Electricity, Express Scripts, Health equity, Food, Parent, Dow Jones, Protection, RE100, CI, ESG, Woman, Housing, DJSI, Health insurance

BLOOMFIELD, Conn., Dec. 19, 2022 /PRNewswire/ -- Cigna Corporation, a global health service company, has been named an industry leader in corporate sustainability for the sixth consecutive year on the Dow Jones Sustainability Indices (DJSI), the most prestigious honor for corporate responsibility and sustainability performances.

Key Points: 
  • BLOOMFIELD, Conn., Dec. 19, 2022 /PRNewswire/ -- Cigna Corporation, a global health service company, has been named an industry leader in corporate sustainability for the sixth consecutive year on the Dow Jones Sustainability Indices (DJSI), the most prestigious honor for corporate responsibility and sustainability performances.
  • This honor also earns inclusion on both the Dow Jones Sustainability™ World Index (DJSI World) and the Dow Jones Sustainability North America Index (DJSI North America).
  • "This honor acknowledges the work we've done, and we are proud to be named as a leader in corporate sustainability.
  • Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 190 million customer relationships around the world.

EATING RECOVERY CENTER AND PATHLIGHT MOOD & ANXIETY CENTER INVESTS IN TEAMMATE ENGAGEMENT TO ADVANCE ITS MISSION OF OFFERING THE HIGHEST QUALITY CLINICAL CARE FOR PATIENTS WITH EATING DISORDERS AND MOOD AND ANXIETY DISORDERS

Retrieved on: 
Monday, December 5, 2022
Acquisition, Eating, Pathlight, Partial hospitalization, Bulimia nervosa, Communication, Depression, Express Scripts, Hospital, Engagement, Diabulimia, UFED, Intensive outpatient program, Panic disorder, Marotta, Home, Binge eating disorder, ERC, ARFID, Black & Veatch, Culture, Multimedia, Anorexia nervosa, Mania, Inclusion, Griswold, Express, Anxiety, Hotel manager, PHP, Post-traumatic stress disorder, IOP, University, Black, Patient, Mental health, Lighthouse, Moses Austin, Medicine, Management

He joins ERC Pathlight in this newly created role to help align the teammate experience with the company’s mission and values.

Key Points: 
  • He joins ERC Pathlight in this newly created role to help align the teammate experience with the company’s mission and values.
  • Sinclair will help strengthen internal communication and engagement efforts to build stronger connections and more rewarding experiences for ERC Pathlight teammates.
  • Eating Recovery Center (ERC) and Pathlight Mood & Anxiety Center (Pathlight) comprise the nation’s leading mental health care system dedicated to the treatment of eating disorders and primary mood, anxiety, and trauma-related disorders.
  • ERC and Pathlight provide innovative, evidence-based, treatment programs tailored for patients of all ages, genders, races, and ethnicities.

To Elevate Service Excellence, D2 makes Senior Leadership Promotions and Adds New Leaders

Retrieved on: 
Thursday, December 1, 2022
Growth, CFO, Specialty pharmacy, HUB, Market access, Pharmacy, ST, Hospital, Rede, Disease management, Pharmacy Council of India, Knowledge, PBM, Pharmaceutical Services Negotiating Committee, Distribution, Strategic planning, Pharmacist, Time-invariant system, Regulation, Express Scripts, Senior, Software as a service, Cancer Treatment Centers of America, Doctor of Pharmacy, Management, Walgreens, Medicaid, D2, Accreditation

ST. LOUIS, Dec. 01, 2022 (GLOBE NEWSWIRE) -- D2 Solutions is an innovative solution provider that helps empower healthcare stakeholders by leveraging SaaS technology with deep consulting expertise to eliminate key friction points in the marketplace to help drive and achieve better efficiency and improve patient results. As part of D2’s ongoing commitment to service excellence, D2 has made two key promotions and added additional resources to better meet client needs and position itself for expansive growth.

Key Points: 
  • As part of D2s ongoing commitment to service excellence, D2 has made two key promotions and added additional resources to better meet client needs and position itself for expansive growth.
  • D2 is excited to announce the promotion of Laura Reibenstein , PharmD, to the position of Chief Operating Officer.
  • Ms. Reibenstein has been with D2 since 2017, most recently serving as Senior Vice President, Accreditation, Regulatory & Specialty Operations.
  • Laura will be working to develop and strengthen the value D2 Solutions offered to clients, collaborating with senior leadership to propel our direction in alignment with our strategy, stated Dean Erhardt , D2 President & CEO.

Arcutis’ ZORYVE® (Roflumilast) Cream 0.3% Added to Express Scripts, Inc.® National Formularies in the United States

Retrieved on: 
Thursday, November 17, 2022
Dermatology, PDE4, Patient, Express, Express Scripts, Dermatitis, Pharmacy, Risk, Formulary, Psoriasis, Atopic dermatitis, Health insurance

Express Scripts commercial national formularies provide access to more than 26 million commercial lives in the United States.

Key Points: 
  • Express Scripts commercial national formularies provide access to more than 26 million commercial lives in the United States.
  • Ensuring affordable access to ZORYVE is of the utmost priority for Arcutis.
  • The inclusion of ZORYVE on Express Scripts national formularies means that our next-generation topical PDE4 inhibitor is now available as a new topical treatment option for millions of adults and adolescents in the United States living with plaque psoriasis, said Frank Watanabe, President and CEO of Arcutis.
  • Were excited by our progress to date and our ability to secure this coverage for ZORYVE with Express Scripts national formularies prior to the end of the year.

Quit Genius Joins the Alight Partner Network with Tobacco Cessation Benefit Offering

Retrieved on: 
Monday, November 14, 2022
Evidence-based practice, Health, Partnership, MAT, Privacy, NYSE, CDC, Pharmacy, Opioid addiction treatment in United States prisons, Tobacco, Quit, Wellness, Nicotine, Growth, Organization, Workplace, Smoking, Express Scripts, Pharmaceutical industry, Alight

NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has partnered with Alight (NYSE: ALIT), a leading cloud-based provider of integrated digital human capital and business solutions, to provide smoking and vaping cessation through Alight’s proprietary Alight Worklife® platform.

Key Points: 
  • With Quit Genius, Alights clients can offer their employees access to the most clinically validated tobacco cessation solution in the market, with biochemically verified 52% quit rates validated in the largest randomized-controlled trial ever undertaken for a digital tobacco cessation program.
  • Having Quit Genius as part of Alights Partner Network enables stronger utilization due to the employee experience the Alight Worklife platform provides.
  • The Quit Genius tobacco cessation program provides a tech-enabled digital clinic designed to help members access evidence-based care wherever they are while helping employers save on healthcare costs.
  • To-date, Quit Genius has helped more than 750,000 people improve their lives and quit their addictions.

VillageMD Acquires Summit Health-CityMD, Creating One of the Largest Independent Provider Groups in the U.S.

Retrieved on: 
Monday, November 7, 2022
Hospitals, Other Retail, Supermarket, Specialty, Convenience Store, Managed Care, Health, Pharmaceutical, Retail, Health, Cigna, Walgreens Boots Alliance, Workforce, Investment, Health care in the United States, Dow Jones, CityMD, Industry, Solution, Pharmacy, Ageing, NYSE, Warburg Pincus, EBITDA, Responsibility, Boot, WBA, Nasdaq, DJSI, CI, EPS, Organization, Family, CEO, Physician, Acceleration, Ownership, Acquisition, Summit, State, Express Scripts, Technology, Calendar, Patient, Walgreens, Hospital, Medicine, Pet, Pharmaceutical industry, Health insurance, Central Oregon

VillageMD announced today it has entered a definitive agreement to acquire Summit Health-CityMD , a leading provider of primary, specialty and urgent care.

Key Points: 
  • VillageMD announced today it has entered a definitive agreement to acquire Summit Health-CityMD , a leading provider of primary, specialty and urgent care.
  • Together, VillageMD and Summit Health-CityMD will create a multi-payor platform to deliver quality, affordable care for all patients.
  • Together, VillageMD and Summit Health will have more than 680 provider locations in 26 markets.
  • Summit Health-CityMD has been a leader in delivering coordinated, multi-specialty care for decades.